Director at NCS Multistage Holdings (NCSM) receives 3,221 RSU award

Rhea-AI Filing Summary

MCSHANE MICHAEL reported acquisition or exercise transactions in this Form 4 filing.

NCS Multistage Holdings, Inc. director Michael McShane reported receiving an equity award of 3,221 shares of common stock in the form of restricted stock units at a price of $0.00 per share. These 3,221 restricted stock units are scheduled to vest and settle on February 28, 2027.

After this grant, McShane’s directly held common stock, including the new restricted stock units, totals 48,778 shares. This is a non-cash, stock-based compensation award rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCSHANE MICHAEL

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,221	$0.00	--

Holdings After Transaction: Common Stock — 48,778 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCSHANE MICHAEL

(Last) (First) (Middle)

C/O NCS MULTISTAGE HOLDINGS, INC.

19350 STATE HIGHWAY 249, SUITE 600

(Street)

HOUSTON TX 77070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NCS Multistage Holdings, Inc. [ NCSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		3,221	A	$0	48,778(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 3,221 restricted stock units which vest and settle on February 28, 2027.

	/s/ Ori Lev, attorney-in-fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did NCS Multistage Holdings (NCSM) report for Michael McShane?

NCS Multistage reported that director Michael McShane received a grant of 3,221 restricted stock units of common stock at $0.00 per share. This award is stock-based compensation and not an open-market share purchase or sale by the director.

How many NCS Multistage (NCSM) shares does Michael McShane hold after this Form 4?

Following the reported equity award, Michael McShane directly holds a total of 48,778 shares of NCS Multistage common stock. This figure includes the newly granted 3,221 restricted stock units that are scheduled to vest and settle on a future date.

When do Michael McShane’s newly granted NCS Multistage (NCSM) restricted stock units vest?

The 3,221 restricted stock units granted to director Michael McShane are scheduled to vest and settle on February 28, 2027. Vesting means the units convert into common shares at that time, assuming applicable conditions are satisfied under the award terms.

Was the NCS Multistage (NCSM) Form 4 transaction an open-market buy or sell?

The reported transaction was not an open-market buy or sell. It was classified as a grant or award acquisition of 3,221 restricted stock units at $0.00 per share, reflecting stock-based compensation rather than a market trade by the director.

What type of security was involved in Michael McShane’s NCS Multistage (NCSM) Form 4 filing?

The filing involves NCS Multistage common stock delivered through 3,221 restricted stock units. These units represent the right to receive common shares in the future, with vesting and settlement scheduled for February 28, 2027, under the terms of the award.